|

Exploring Biomarkers of the Carcinogenesis of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas

RECRUITINGSponsored by Zhejiang University
Actively Recruiting
SponsorZhejiang University
Started2022-07-01
Est. completion2032-06-30
Eligibility
Age0 Years – 90 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05433935

Summary

This is a prospective, open large cohort study to explore biomarkers for detecting early carcinogenesis of IPMN.

Eligibility

Age: 0 Years – 90 YearsHealthy volunteers accepted
Inclusion Criteria:

* clinically diagnosed as IPMN;
* without other malignant tumor;
* agree to sign informed consent.

Exclusion Criteria:

* with mental disorders which can affect cognition and cooperation;
* with serious blood diseases or taking drugs that can affect peripheral blood

Conditions2

CancerIntraductal Papillary Mucinous Neoplasm

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.